Capahc is pleased to annonce good new for people living with hepatitis C.
The province of Quebec is now reimbursing ZEPATIER® (elbasvir/grazoprévir) for hepatitis C patients.
This new DAA is for patients with Genotype 1a, 1b or 4, with or without cirrhosis, and particulary for renally impaired and dialysis patients.
For more information, click on the link below: